openPR Logo
Press release

Investigation for Investors in NASDAQ: APYX shares over potential Securities Laws Violations by Apyx Medical Corporation

04-02-2020 02:38 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx

An investigation for investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx

An investigation was announced on behalf of investors of Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx Medical Corporation.

Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation (NASDAQ: APYX regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Clearwater, FL based Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation reported that its annual Total Revenue rose from $16.68 million in 2018 to $28.15 million in 2019 and that its Net Income of $64 million in 2018 declined to a Net Loss of $19.65 million in 2019.

On March 16, 2020, Apyx Medical Corporation announced that its financial statements for the twelve months ended December, 31 2018 and the quarterly statements for the three and nine months ended September 30, 2018 and three months ended March 31, 2019 could no longer be relied upon and would need to be restated.

Shares of Apyx Medical Corporation (APYX) declined from $8.56 per share on January 3, 2020, to as low as $2.92 per share on March 23, 2020.

Those who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in NASDAQ: APYX shares over potential Securities Laws Violations by Apyx Medical Corporation here

News-ID: 1995674 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Apyx

Lawsuit filed for Investors in shares of Apyx Medical Corporation (NASDAQ: APYX)
An investor, who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), filed a lawsuit over alleged violations of Federal Securities Laws by Apyx Medical Corporation. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2022. NASDAQ: APYX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Clearwater FL based Apyx
Investigation announced for Investors in shares of Apyx Medical Corporation (NAS …
An investigation was announced over potential securities laws violations by Apyx Medical Corporation in connection with certain financial statements. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation regarding its business, its prospects and its operations were
Cold Plasma Market Comprehensive Analysis Reveals Superb Growth | Apyx Medical C …
The market report provides a recent estimate and forecast for the global Cold Plasma Market at the global, corporate, and regional levels. The report offers a detailed overview of global demand for Cold Plasma Market from 2016 to 2028, with 2016 as the base year and 2028 as the projected end date. Data for 2016-2028 has been included, along with information and analyses of previous results. The market study discusses
Global Cold Plasma Market Opportunity Assessment 2021-2026 ||Apyx Medical Corpor …
Advance Market Analytics published a new research publication on "Cold Plasma Market Insights, to 2026" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market stakeholders. The growth of the Cold Plasma market is mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy
Investigation announced for Long-Term Investors in Apyx Medical Corporation (NAS …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Apyx Medical Corporation. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Apyx Medical directors breached their fiduciary duties and caused damage to the company and its shareholders. Clearwater, FL
Cold Plasma Equipment Market Key Market Opportunities and Future Trends - Plasma …
Cold plasma is proved very effective in the biomedicine. Cold plasma is used in many medical treatments such as, wound healing, cancer, dermatology, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, and inflammation, disinfection and scar treatment. Cold plasma's ability to kill bacteria, including the drug-resistant bacteria, to avoid further infection, helps in chronic wounds. This accelerates the process of wound healing and prevents further complications and the related discomforts.